Yagome Susumu, Ohsugi Mitsuru, Sugiyama Takehiro, Bouchi Ryotaro, Goto Atsushi, Ueki Kohjiro
Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan.
Integrity Healthcare Co., Ltd., Tokyo, Japan.
GHM Open. 2024 Jul 31;4(1):18-22. doi: 10.35772/ghmo.2023.01014.
We assessed trends in glycemic control among individuals with diabetes before and during the coronavirus disease 2019 pandemic. We used two databases to investigate changes in prescription days and the interval between physician visits and their impact on glycemic control among individuals with diabetes in Japan between 2017 and 2020. The analysis using the JMDC database indicated that prescription days were extended by approximately 20 days in 2020 compared to other years. The analysis using the Japan diabetes comprehensive database project based on an advanced electronic medical record system database revealed that intervals between physician visits were extended by approximately 7 days in 2020 compared to other years and glycemic control did not materially change in 2020. These results suggest that the prescription days increased with the spread of coronavirus disease 2019 in patients with diabetes, but the impact of the coronavirus disease 2019 pandemic on glycemic control appeared to be small.
我们评估了2019冠状病毒病大流行之前及期间糖尿病患者的血糖控制趋势。我们使用两个数据库来调查2017年至2020年期间日本糖尿病患者的处方天数变化、医生就诊间隔及其对血糖控制的影响。使用JMDC数据库的分析表明，与其他年份相比，2020年的处方天数延长了约20天。使用基于先进电子病历系统数据库的日本糖尿病综合数据库项目进行的分析显示，与其他年份相比，2020年医生就诊间隔延长了约7天，且2020年血糖控制没有实质性变化。这些结果表明，随着2019冠状病毒病的传播，糖尿病患者的处方天数增加，但2019冠状病毒病大流行对血糖控制的影响似乎较小。
